Erythropoietin and Parkinson's disease: Suggested mechanisms and therapeutic implications.
Genc
Kursad
K
D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D004921:Erythropoietin / Q000502:physiology* / Q000627:therapeutic use*; D006801:Humans; D051267:NF-E2-Related Factor 2 / Q000502:physiology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*
D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D018696:Neuroprotective Agents; D004921:Erythropoietin